Ajanta Pharma gets USFDA nod for generic asthma treatment drug
Economic Times NEW DELHI: Drug firm Ajanta Pharma has received final approvals from the US health regulator for generic montelukast tablets and oral granules used for prevention and treatment of asthma and to relieve symptoms of seasonal hay fever. The company has … |
View full post on asthma – Google News